Ozempic v. Mounjaro? There’s a clear winner for weight loss, study finds
Share this
Recent posts
-
Understanding real-world patterns of increasing oral semaglutide dose for obesity
-
Shingrix at 50: A good-news story for adult vaccination, healthy aging, and real-world study design
-
Shingrix vaccination is rising among newly eligible adults, but access gaps remain
-
Progesterone-containing hormone replacement therapy use is rising
-
Generating synthetic clinical notes to improve biomedical AI
Follow Truveta
Stay up-to-date